Company intelligence / Profile preview

Bioscience Institute

Ownership: Private
Employees: ~42
Development stage: Other

Overview

Bioscience Institute offers commercial stem cell banking and expansion, autologous cell therapies, and advanced personalized genomic screening; clinical applications include regenerative medicine across anti-aging, wound care, reproductive health, and cancer prevention. The company operates laboratories and clinics in San Marino, Rome, and Dubai, and collaborates with academic institutions for R&D[1][3][5].

Therapeutic areas: OncologyImmunologyOtherDermatologyWomen's Health
Modalities: Stem cell therapyExosome-based therapyCell therapyGenomic screening
Industry: Biotech

Drug pipeline

9 assets

Cellskill

Preclinical

8 more assets in the full pipeline.

Partnerships

University of Rome "Tor Vergata"

Beyond the preview

Go deeper on Bioscience Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioscience Institute.